ObvioHealth
PrivateLast Round
Series B
Extension
Jul 25, 2024
Total Funding Raised
$69.4M
Company Overview
ObvioHealth operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B Extension round in July 2024.
ObvioHealth is a healthcare technology company that provides an end-to-end virtual research organization (VRO) platform designed to facilitate decentralized and hybrid clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Biotechnology, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ObvioHealth Comparables
Compare ObvioHealth with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| THREAD | 91% | |
| ProofPilot | 89% | |
| Curavit | 86% |
For institutional investors. Book with your work email.
ObvioHealth Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 25, 2024 | ||||
| Series B | Jul 1, 2021 | ||||
| Series A | May 20, 2020 | ||||
| Series A | Mar 23, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ObvioHealth Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tikehau Capital | Series A |
| SPRIM Global Investments | Series A, Series B |
| Tikehau Investment Management | Series A |
| AT Capital Group | Series B |
| SPRIM Global Investments | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2026
Novotech Group selected ObvioGo platform for multi-trial license.
- Jul 7, 2025
Added PhRMA, a pharmaceutical trade association, as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 10, 2026
Obvio Health USA, Inc. and SPRIM PRO launch the Integrated Digital Patient Monitoring and Clinical Support Solution for High-Risk Therapies, which integrates digital health technology, clinical operations, and patient support services into one offering on Sep 10th '26.
For institutional investors. Book with your work email.
ObvioHealth Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ObvioHealth's valuation, stock price, and market status.
Is ObvioHealth a public or private company?
ObvioHealth is a private company.
What is the current stock price of ObvioHealth?
ObvioHealth is a private company, so its shares have no public market price. Caplight tracks ObvioHealth's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ObvioHealth worth (valuation)?
Valuation information for ObvioHealth is not publicly available.
Can I buy ObvioHealth stock?
ObvioHealth shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ObvioHealth's last funding round?
ObvioHealth's most recent funding round was Series B Extension on July 25, 2024.
Who are the main investors in ObvioHealth?
Key investors in ObvioHealth include SPRIM Global Investments.
Will ObvioHealth IPO soon?
No public IPO plans have been announced for ObvioHealth.
How can I track ObvioHealth secondary market activity?
Caplight tracks bids, offers, and trades in ObvioHealth's shares on secondary markets.